EDGAR Filing Documents for 0001213900-20-002261

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001213900-20-002261

Filing Date

2020-01-31

Accepted

2020-01-31 16:08:58

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	fs32020_oramedpharma.htm	S-3	241015
2	OPINION OF ZYSMAN, AHARONI,GAYER AND SULLIVAN & WORCESTER LLP.	fs32020ex5-1_oramedpharma.htm	EX-5.1	12598
3	CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	fs32020ex23-1_oramedpharma.htm	EX-23.1	5562
4	GRAPHIC	image_001.jpg	GRAPHIC	7469
5	GRAPHIC	image_002.jpg	GRAPHIC	31043
6	GRAPHIC	image_003.jpg	GRAPHIC	8013
7	GRAPHIC	image_003.gif	GRAPHIC	1854
	Complete submission text file	0001213900-20-002261.txt		327536

Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164

ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)